Hydrocortisone and acetic acid otic solution, Rx only, 10 mL bottle, Distributed by Actavis Inc. ...

FDA Drug Recall #D-1472-2016 — Class III — August 2, 2016

Recall Summary

Recall Number D-1472-2016
Classification Class III — Low risk
Date Initiated August 2, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Actavis Inc
Location Parsippany, NJ
Product Type Drugs
Quantity 2543 bottles

Product Description

Hydrocortisone and acetic acid otic solution, Rx only, 10 mL bottle, Distributed by Actavis Inc. 60 Columbia Road Bldg B. Morristown, NJ 07560 USA , NDC 45963-412-61

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

L503092, Exp 04/2016

Other Recalls from Actavis Inc

Recall # Classification Product Date
D-0514-2017 Class III Levofloxacin Ophthalmic Solution, 0.5%, Sterile... Feb 7, 2017
D-0476-2017 Class II Glipizide extended-release tablets, 2.5mg, 30-c... Jan 30, 2017
D-0439-2017 Class III Albuterol Sulfate Inhalation Solution, USP, 0.0... Jan 12, 2017
D-1471-2016 Class III Acetasol HC (hydrocortisone and acetic acid oti... Aug 2, 2016
D-1448-2016 Class II Dextroamphetamine Sulfate Extended-Release Caps... Jul 11, 2016

Frequently Asked Questions

Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.